The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management<subtitle>The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</subtitle>
Abstract
BACKGROUND: Despite clear evidence for the efficacy of lowering cholesterol levels, there is a deficiency in its real-world application. There is a need to explore alternative strategies to address this important public health problem. This study aimed to determine the effect of a program of community pharmacist intervention on the process of cholesterol risk management in patients at high risk for cardiovascular events. METHODS: A randomized controlled trial conducted in 54 community pharmacies (1998-2000) included patients at high risk for cardiovascular events (with atherosclerotic disease or diabetes mellitus with another risk factor). Patients randomized to pharmacist intervention received education and a brochure on risk factors, point-of-care cholesterol measurement, referral to their physician, and regular follow-up for 16 weeks. Pharmacists faxed a simple form to the primary care physician identifying risk factors and any suggestions. Usual care patients received the same brochure and general advice only, with minimal follow-up. The primary end point was a composite of performance of a fasting cholesterol panel by the physician or addition or increase in dose of cholesterol-lowering medication. RESULTS: The external monitoring committee recommended early study termination owing to benefit. Of the 675 patients enrolled, approximately 40% were women, and the average age was 64 years. The primary end point was reached in 57% of intervention patients vs 31% in usual care (odds ratio, 3.0; 95% confidence interval, 2.2-4.1; P<.001). CONCLUSIONS: A community-based intervention program improved the process of cholesterol management in high-risk patients. This program demonstrates the value of community pharmacists working in collaboration with patients and physicians.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Opportunities and responsibilities in pharmaceutical care
Hepler, C. D., & Strand, L. M. (1990) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/47.3.533 · Cited by 2,895
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Ohn, D, R., Utherford, Homas, G., C., Ole, J, M., Alcolm, O., A., & Rnold (2000) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199701000-00013 · Cited by 2,026
Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making
Soumerai, S. B. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440040088034 · Cited by 1,084
Pearson, T. A., Laurora, I., Chu, H., & Kafonek, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.459 · Cited by 1,012
Brook, R. H., McGlynn, E. A., & Cleary, P. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351311 · Cited by 769
Bowker, T. J., Clayton, T. C., Ingham, J., McLennan, N. R., Hobson, H. L., Pyke, S. D., Schofield, B., & Wood, D. A. (1996) · Heart · doi:10.1136/hrt.75.4.334 · Cited by 305
Sueta, C. A., Chowdhury, M., Boccuzzi, S. J., Smith, S. C., Alexander, C. M., Londhe, A., Lulla, A., & Simpson, R. J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00117-4 · Cited by 266
Pharmaceutical Care Services and Results in Project ImPACT: Hyperlipidemia
Bluml, B. M., McKenney, J. M., & Cziraky, M. J. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31059-2 · Cited by 258
Schumock, G. T., Meek, P. D., Ploetz, P. A., & Vermeulen, L. C. (1997) · PubMed · Cited by 247
McBride, P., Schrott, H. G., Plane, M. B., Underbakke, G., & Brown, R. L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1238 · Cited by 228
Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines
Frolkis, J. P., Zyzanski, S. J., Schwartz, J. M., & Suhan, P. S. (1998) · Circulation · doi:10.1161/01.cir.98.9.851 · Cited by 191
Hoerger, T. J., Bala, M. V., Bray, J. W., Wilcosky, T. C., & LaRosa, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00227-6 · Cited by 167
Mindlen, F., Nordaby, R. A., Ruiz, M. I. S., Nava-Zavala, A. H., Guzmán, L., Martínez, F., Díaz, R., Mackey, C., Marino, M., Romero, G. S., et al. (1996) · PubMed · Cited by 160
Economic Evaluations of Clinical Pharmacy Services—1988–1995
Publications Committee of the American College of Clinical Pharmacy, Schumock, G. T., Meek, P. D., Ploetz, P. A., & Vermeulen, L. C. (1996) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb03049.x · Cited by 160
Comprehensive Pharmaceutical Care in the Chain Setting
Park, J. J., Kelly, P. J., Carter, B. L., & Burgess, P. P. (1996) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30099-7 · Cited by 155
Robinson, P. R., & Simon, T. (1988) · Physiotherapy · doi:10.1016/s0031-9406(10)63531-6 · Cited by 149
Cohen, M. V., Byrne, M. J., Levine, B. C., Gutowski, T., & Adelson, R. (1991) · Circulation · doi:10.1161/01.cir.83.4.1294 · Cited by 137
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
Majumdar, S. R., Gurwitz, J. H., & Soumerai, S. B. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.02229.x · Cited by 130
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
&NA; (1996) · The Endocrinologist · doi:10.1097/00019616-199605000-00022 · Cited by 124
Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting
Munroe, W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80078-1 · Cited by 122
Pharmacy beyond the dispensary: general practitioners' views.
Spencer, J. A., & Edwards, C. (1992) · BMJ · doi:10.1136/bmj.304.6843.1670 · Cited by 115
Giles, W. H. (1993) · JAMA · doi:10.1001/jama.269.9.1133 · Cited by 111
Pearson, T. A., & Peters, T. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00820-5 · Cited by 109
McCormick, D., Gurwitz, J. H., Lessard, D., Yarzebski, J., Gore, J. M., & Goldberg, R. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.561 · Cited by 107
Promoting Better Health'. The Government's programme for improving primary health care
(1987) · BDJ · doi:10.1038/sj.bdj.4806310 · Cited by 91
The Physician and Pharmacist Team An Effective Approach to Cholesterol Reduction
Bogden, P. E., Koontz, L. M., Rph, Williamson, P., PharmD, & Abbott, R. D. (1997) · Journal of General Internal Medicine · doi:10.1007/s11606-006-5023-7 · Cited by 88
Jacobson, T. A., Griffiths, G. G., Varas‐Lorenzo, C., Gause, D. O., Sung, J. C. Y., & Ballantyne, C. M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1361 · Cited by 77
Hatoum, H. T., & Akhras, K. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700917 · Cited by 68
Tsuyuki, R. T., Johnson, J. A., Teo, K. K., Ackman, M. L., Biggs, R. S., Cave, A., Chang, W.-C., Džavík, V., Farris, K. B., Galvin, D., et al. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18380 · Cited by 67
Self-citationSimpson, S. H., Johnson, J. A., & Tsuyuki, R. T. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.6.627.34538 · Cited by 56
Self-citationTask force 4. Efficacy of risk factor management
Forrester, J. S., Merz, C. N. B., Bush, T. L., Cohn, J. N., Hunninghake, D. B., Parthasarathy, S., & Superko, H. R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)87732-1 · Cited by 55
Preventive care and barriers to effective prevention. How do family physicians see it?
Hutchison, B. G., Abelson, J., Woodward, C. A., & Norman, G. R. (1996) · PubMed Central · Cited by 49
Community pharmacists' participation in health education and disease prevention activities.
Paluck, E., Stratton, T. P., & Eni, G. O. (1995) · PubMed · Cited by 40
Tett, S. E., Higgins, G. M., & Armour, C. L. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700118 · Cited by 34
Pearson, T. A., Brown, W. V., Donato, K., Franklin, F. A., Luepker, R. B., McBride, P. E., Mullis, R. M., Scott, L. W., SHANNON, B. M., & Shekelle, R. B. (1993) · Circulation · doi:10.1161/01.cir.88.3.1397 · Cited by 17
Cholesterol Management in Patients Hospitalized for Coronary Heart Disease
Boekeloo, B. O., Becker, D. M., LeBailly, A., & Pearson, T. A. (1988) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)31184-x · Cited by 14
Cited by
Clinical and economic outcomes of medication therapy management services: The Minnesota experience
Isetts, B. J., Schondelmeyer, S. W., Artz, M. B., Lenarz, L. A., Heaton, A. H., Wadd, W. B., Brown, L. M., & Cipolle, R. J. (2008) · Journal of the American Pharmacists Association · doi:10.1331/japha.2008.07108 · Cited by 387
Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k311 · Cited by 378
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns
Nkansah, N., Mostovetsky, O., Yu, C., Chheng, T., Beney, J., Bond, C. M., & Bero, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000336.pub2 · Cited by 343
Interventions to improve adherence to lipid-lowering medication
van Driel, M. L., Morledge, M. D., Ulep, R., Shaffer, J. P., Davies, P., & Deichmann, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004371.pub4 · Cited by 333
Santschi, V. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.399 · Cited by 296
Metadata
- Authors
- Tsuyuki, R. T.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2002-05-27
- Volume
- 162
- Issue
- 10
- Pages
- 1149
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2136453117
- Cited by
- 290
- References
- 47
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.